Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 5,795
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Suada Ibrahim Suleiman
ID:
PREVALENCE AND FACTORS ASSOCIATED WITH ABNORMAL CEREBROPLACENTAL RATIO AMONG WOMEN WITH HYPERTENSIVE DISORDERS AT MBARARA REGIONAL REFERRAL HOSPITAL
REFNo: HS2581ES

To determine the prevalence and factors associated with abnormal fatal Cerebroplacental ratio among women with preeclampsia at Mbarara Regional Referral Hospital.
Uganda 2023-06-27 10:44:45 2026-06-27 Medical and Health Sciences Non-Clinical Trial Degree Award
Racheal Nansereko Kabuye
ID:
PURCHASING MANAGEMENT PRACTICES AND GROWTH OF MICRO AND SMALL ENTERPRISES IN UGANDA: A CASE OF SELECTED WOMEN RESTAURANTS IN KCCA MARKETS
REFNo: SS1822ES

The main objective of this study is to analyze the contribution of purchasing management practices on the growth Micro and Small enterprises in Uganda, focusing specifically on selected women restaurants in KCCA markets. ,
Uganda 2023-06-23 7:48:28 2026-06-23 Social Science and Humanities Non-Clinical Trial Degree Award
Ezekiel Mupere
ID: UNCST-2023-R008637
Earlier prime-BOOST schedule to improve MEasles protection in high burden settings (BoostME)
REFNo: HS2883ES

Safety Objectives 1.To assess the safety and reactogenicity profile of the vaccine when given at different ages 2.To assess the number of measles infections throughout the study. Primary Objectives 1.To compare protective measles antibody concentrations at 2.5 years of age in infants receiving an early (6 months) compared to standard (9 month) dose of MCV, and a booster dose at 18 months of age. 2.To compare protective measles antibody concentrations one month after a second dose of MCV given at 12 months (early) compared to standard (18 months), in those who received an early (6 months) first dose. Secondary Objectives •To describe the measles antibody concentrations one month after first dose in infants receiving an early (6 months) compared to standard (9 month) dose of MCV. •To describe the effect of maternal antibodies on infant humoral and cellular immune response to first and second doses in children vaccinated under different schedules. •To describe the effect of maternal HIV infection on infant antibody responses post MCV1 and MCV2 given at different schedules •To describe the impact of different vaccination schedules on responses to the rubella component of the vaccine. Community Objectives To assess the effect of a measles vaccination clinical trial on public perceptions of measles immunisation
Uganda 2023-06-23 7:46:04 2026-06-23 Medical and Health Sciences Clinical Trial Non-degree Award
David Musoke
ID:
Community Perceptions and Experiences of response to the Ebola Virus Disease outbreak in Uganda
REFNo: HS2904ES

To explore community perceptions and experiences of the EVD response in Uganda to provide recommendations to inform guidelines / standard operating procedures (SOPs) on responding to the disease (and other epidemics).
Uganda 2023-06-20 9:46:33 2026-06-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
David Aziku
ID: UNCST-2023-R007595
2nd Analytical Study of Plan International’s Sponsorship Programs
REFNo: SS1806ES

The primary research objective of the current project is to deepen the understanding of sponsorship impacts at the country level
Uganda 2023-06-20 9:44:49 2026-06-20 Social Science and Humanities Non-Clinical Trial Non-degree Award
Barbara Balikuddembe  Ndagire Balikuddembe
ID:
The Informed Consent Process for Fixed Prosthodontic Treatment in Kampala Metropolitan Area, Uganda: Practices, Patient Understanding, Development and Validity of a Multimedia Intervention
REFNo: HS2914ES

To develop and validate a multimedia informed consent tool for fixed prosthodontic treatment. ,To establish patients’ understanding of consent information provided for fixed prosthodontic treatment in Kampala metropolitan area, Uganda,To determine the adequacy of information given to patients during consent for fixed prosthodontic treatment in Kampala metropolitan area, Uganda,To explore dentists’ perspectives, practices and associated factors regarding the informed consent process for fixed prosthodontic treatment in Kampala metropolitan area, Uganda,To improve the informed consent processes for fixed prosthodontic treatment among dentists in Uganda,
Uganda 2023-06-20 9:41:47 2026-06-20 Medical and Health Sciences Non-Clinical Trial Degree Award
Elizabeth Babirye Katana
ID: UNCST-2022-R009762
Determinants of COVID-19 vaccination uptake and hesitancy among special groups (pregnant/lactating women, persons with chronic conditions and those aged over 50 years) in Kampala.
REFNo: HS2929ES

To explore the differences in the level of uptake and willingness to receive the COVID-19 vaccine among pregnant/lactating women, persons with chronic conditions and those aged over 50 years in selected communities of Kampala district,1. To identify the factors associated with the level of uptake and willingness to receive the COVID-19 vaccine among pregnant/lactating women, persons with chronic conditions and those aged over 50 years in selected communities of Kampala district ,To determine the level of uptake and willingness among pregnant/lactating women, persons with chronic conditions and those aged over 50 years in selected communities of Kampala district in Uganda to receive the COVD-19 vaccine.,
Uganda 2023-06-20 9:39:21 2026-06-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Christine  Wiltshire Sekaggya
ID: UNCST-2019-R000578
EVALUATION OF PATIENT DATA FROM THE HAEMAOLOGY UNIT OF MULAGO HOSPITAL (HAEM COHORT)
REFNo: HS2731ES

1.To describe the hematological conditions, demographic, clinical and social factors of patients and their outcomes and create a database of an open cohort of patients attending the Mulago hematology out- and in-patient unit using routinely collected data.

2.To evaluate the blood transfusion process and practices of patients admitted in the Mulago Hematology ward using data from patient files and Mulago blood bank records

Uganda 2023-06-20 9:34:25 2026-06-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Ezra Rwakazooba Aliija
ID:
Understanding Financial Access in the Mid channel players in Agricultural Value Chains in Arabica coffee and soybean in Eastern, Western and Northern Uganda.
REFNo: SS1803ES

Disaggregating these statistics by the following categories: (a) gender and (b) type of mid channel actor (i.e. traders, transporters, processors, aggregators, wholesalers, etc.),The study is intended to develop value chain-level representative statistics among different mid channel actors (i.e. aggregators, traders, processors, wholesalers) related to the proportion of actors with access to formal, informal, or adequate financial services, the proportion actors already using digital products (i.e. mobile money, digital payment systems, etc.) to facilitate financial transactions and what unmet financial needs exist that may be addressed by digital financial services. ,
Uganda 2023-06-20 17:20:35 2026-06-20 Social Science and Humanities Non-Clinical Trial Non-degree Award
Heidi Thorsdalen Høghaug
ID: UNCST-2022-R011550
Am I too dirty to touch my baby? Providers’ and users’ perceptions of a hand hygiene intervention in the neonatal period: A Qualitative study in Eastern Uganda
REFNo: HS2240ES

Objectives:

Main Objective

1. Explore the health workers’ and household members’ perceptions of the BabyGel intervention.
Specific Objectives

1. Explore how the ABHR intervention was perceived by adult household members; what aspects of the intervention as indcated were seen as barriers and facilitating during the 3 months follow-up.
2. Inquire the health workers’ experiences providing the BabyGel training, and aspects of the training and intervention as a whole that they perceived as helping or hindering good ABHR use in households, and its scalability.
Norway 2023-06-20 12:22:35 2026-06-20 Medical and Health Sciences Non-Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."